Profile

Recruiters: To view this profile, please Register / Login

Jobseekers: To make your profile available to Recruiters for free, opt for Premium Membership

Dr Venkatesh Mushini DHA licence unique ID 94768574

Candidate ID: 1650318

Career Summary

I am Dr Venkatesh Mushini MD DM MRCP - MEDICAL ONCOLOGY working as a Senior Consultant Medical oncologist & Hemato oncologist with expertise in treating all types of cancers including both Solid & Hematological malignancies with 10 years of experience in the field of clinical oncology.

Skill Set

Expertise in treating all types of cancer including both solid and Hematological malignancies. Expertised in treating cancers with chemotherapy,Targeted therapy,Immunotherapy & Hormonal therapy. Certified in Pain & Palliative care. Actively involved in Clinical research & academic activities.

Professional Information

Total Experience : 10

Nationality : India

Qualification Level : Doctorate

Job Function : Doctor / Medical Research / Dean / Medical Professors

Work Location Preference : Kuwait, Bahrain, Oman, Saudi Arabia, Qatar, UAE

Detailed Profile

Dr VENKATESH MUSHINI, MD DM MRCP - Senior consultant Medical oncologist & Hemato oncologist

Email ayaananees22@gmail.com, venky.mushinidvk@gmail.com

Phone +918520891129
Date of birth Nov 8, 1985
Nationality Indian DHA Unique ID 94768574

OBJECTIVE

• Qualified Medical professional with 7 years of experience in the field of clinical Oncology (Radiation oncology, Medical Oncology & Hematooncology).
• Expertise in managing all types of Malignancies
• DHA Eligibility letter holder – Specialist Medical Oncology
• Highly skilled in administration of all types of chemotherapy, targeted therapy, hormonal therapy , molecular therapy and Immunotherapy as per International standards


EXPERIENCE

Democratic Republic of Congo
Feb 2022 – January 2023
Chief consultant Medical oncologist and Head of Department of Oncology Padiyath medicity hospital du cinquantanaire

• Proficient in diagnosing cancers, using Biopsy, endoscopy, X-ray, CT scanning, MRI, PET scanning, ultrasound or other radiological methods; used nuclear medicine, as well as blood tests and tumor markers for diagnosis; expertise in Bone Marrow Aspiration, Biopsy and Molecular Genomic Profiling of the Tumor.
• Expertise in treating Adult and Paediatric oncology, all types of cancers (Solid as well as Hematological cancers) cases with detailed diagnosis, treatment, prognosis and follow up with patient tailored treatment
• Monitering Patient throughout the course of the disease, including palliative care
• Specialist in use of Latest molecules of Chemotherapy, Hormone therapy, Monoclonal Antibodies, Immunotherapy and Analgesics in Cancer and Pain Management.


India
- August 2017-January 2022 Consultant Medical Oncologist Global Hospital
• Daily used to manage 30-40 patients of Solid and Hematological malignancies in the outpatient clinic (OPD)& Inpatient (IPD).

• India
Jan 2014-July 2014 : Consultant Clinical Oncologist
Susrutha Cancer Hospital
• Expertise in administrating all types of chemotherapy
• Well experienced in advanced techniques of Radiotherapy

EDUCATION

U.K U.K

Jul 2018 - Jul 2019
MRCP PART 1 INTERNAL MEDICINE
Royal college of physcians

2018 - 2019
MRCP MEDICAL ONCOLOGY
Royal college of physcians



India India

Aug 2014 - Jul 2017
DM MEDICAL ONCOLOGY
Dr.NTR University

May 2010 - May 2013
MD Doctorate of Medicine
Dr.NTR University



India
Oct 2002 - Oct 2007
MBBS
Dr.NTR University

SKILLS LANGUAGES


• Strong communication ,interpersonal and Leadership Skills
• caring and compassionate in nature
• Hard working, sincere and responsible
• Problem Solving
MEMBERSHIPS

Professional memberships and Associations

2019: Association of Immuno Oncology Society of India (IOSI)

2017: European Society of Medical oncology (ECMO)

2015: Indian Society of Medical & Pediatric Oncology (ISMPO)

2013: Indian Medical Association (IMA)

2011: Association of Radiation Oncologists of India (AROI)


French
Elementary

Hindi
Intermediate


English
Advanced



CERTIFICATIONS & COURSES

• European Society of Medical Oncology Board (ECMO), Certified European Society of Medical Oncology,2017
• John Hopkins Online Certification - Immunotherapy in Adjuvant and Metastatic Lung Cancer,2019
• The University of Texas MD Anderson Cancer Center Online Certification Immunotherpay in Cancer Patients & Role of EGFR TKIs in Lung Cancer, 2019
• Duke Health Online Certification - Advanced Breast Cancer Management, 2019
• European Society of Immunooncology ;2021



HONORS & AWARDS

• Best of ASCO, 2018 Delivered National Level Talk on role of Immunotherapy in Squamous cell ca Lung (Key Note 407 Study)
• State speaker. on Role of Sub Cutaneous Herceptin in Breast Cancer -2018

• Honoured at District level Cancer Care in India,2019
• Acted as CME on overview of Chemotherapy and Advances in Medical Oncology, 2019
• State Level Talk on updates in CINV and role of Akynzeo(NEPA),2018
• Participated as a key speaker in several Cancer Awareness Programs conducted at community level
• Attended Several International and National Conferences as a Delegate and Speaker in last 10 years (World Cancer Congress-2018; ASCO-2017



PAPERS AND PUBLICATIONS

As Primary Author
• A rare case of Non Hodgkin Lymphoma of Nasopharyngeal origin with unusual pattern of relapse; ISMPO 2015 Abstract
• A rare incidence of late recurrence of primary as double malignancy ; ISMPO 2015 Abstract
• A rare presentation of carcinoma lung as sofi tissue mass ; ISMPO 2015 Abstract
• Clinical profile &therapy of Hepatocellular carcinoma in a tertiary care -Hospital in Andhrapradesh from South India A study of 182 cases - ACOS 2016 ; Oral presentation.
• Clinical profile and outcomes of acute myeloid leukemia: An institutional experience from South India- HEMATOCON 2016 - Abstract

As Second Author
• Synchronous Occurrence of CML and Ca Breast-A RareCombination-HEMATOCON,2016-Abstract
• The different clinical scenarious of Plasmablastic Myeloma: A report of two cases of very rare variant ofmultiple Myeloma-ISMPO, 2016-Abstract
• Paediatric CML Data-An Insitutional experience from South India-APCON,2017-Abstract

Publications Peer reviewed - Corresponding Author
• Clinical profile and Therapy of Hepatocellular Carcinoma at aTeritaryCare Institute from South India: A Retrospective study of 182 patients- IJCER Vol 5no 1,january
june2017DOI:http:/ dx.doi.org/10.21088/ijcer.2321.9815.5117.5
• A study of COX-2 inhibitor celecoxib and chemoradiation in patients with locally advanced Cervical Cancer - Jebmh.com Co author J. Evid. Based Med. Healthc., pISSN- 2349-2562, eISSN- 2349-2570/ Vol. 3/Issue 68/Aug. 25, 2016

• Treatment Response and Locoregional Control in Locally Advanced Oral Cavity Cancers with Concurrent Chemoradiation and Radiation Alone Co author Indian Journal of Cancer Education and Research 53 Volume 5 Number 2, July - December 2017 DOI: http:/ dx.doi.org/10.21088/ijcer.2321.9815.5217.1
• Comparative Study of Folfox 4 Versus Capeox Chemotherapy Regimens in Adjuvant Therapy and Metastatic Colorectal Cancer Indian Journal of Cancer Education and Research Volume 7 Number 2, July - December 2019 DOI: http:/ dx.doi.org/10.21088/ijcer.2321.9815.7219.6
• Clinical Profile and Outcomes of Acute Myeloid Leukemia: An Institutional Experience from South India. Indian Journal of Cancer Education and Research Volume 7 Number 2, July - December 2019 DOI:
http:/ dx.doi.org/10.21088/ijcer.2321.9815.7219.7




REFERENCES

Dr.Silas Charles MD American Board certified Radaition oncologist ., +1(321)7957390, Florida ,USA. Dr.BHPS Veeraju Consultant Surgical oncologist MD Global cancer Hospital ., =91 9848124080., India